The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion on Fabhalta for kidney disease.
https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-positive-opinion-for-Fabhalta-in-the-EU-49199995/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.